Literature DB >> 9489664

Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).

P B Joshi1, D L Sacks, G Modi, W R McMaster.   

Abstract

The major surface glycoprotein of Leishmania major is a zinc metalloproteinase of 63 kDa referred to as leishmanolysin or GP63, which is encoded by a family of seven genes. Targeted gene replacement was used to delete gp63 genes 1-6 encoding the highly expressed promastigote and constitutively expressed GP63. In the L. major homozygous mutants deficient in gp63 genes 1-6, there was no expression of GP63 as detected by reverse transcription-polymerase chain reaction (RT-PCR) or fluorescent staining in promastigotes from the procyclic stage (logarithmic growth phase). The remaining L. major gP63 gene 7 was shown to be developmentally regulated, as it was expressed exclusively in infectious metacyclic stage (late stationary growth phase) promastigotes and in lesion amastigotes. The gp63 genes 1-6-deficient mutants showed increased sensitivity to complement-mediated lysis. The sensitivity to lysis was greater in procyclics than in metacyclics when compared with the equivalent wild-type stages. Increased resistance of the mutant metacyclic promastigotes correlated with the expression of gp63 gene 7 and was restored to the same levels as wild-type promastigotes by transfection with gp63 gene 1. Thus, expression of GP63 is clearly involved in conferring resistance to complement-mediated lysis. The L. major GP63 1-6 mutants were capable of infecting mouse macrophages and differentiating into amastigotes. Similar levels of infection and subsequent intracellular survival were observed when mouse macrophages were infected in vitro with wild type, GP63 1-6 mutants and mutants transfected with gp63 gene 1. The GP63 1-6 mutants were capable of lesion formation in BALB/c mice and, thus, gp63 genes 1-6 do not play a role in the survival of the parasite within mouse macrophages. The role of gp63 genes 1-6 in parasite development within the sandfly vector was studied. GP63 1-6 mutants grew normally in the blood-engorged midgut of both Phlebotomus argentipes and P. papatasi However, both wild-type and mutant promastigotes were lost after 2 days' growth in P. papatasi. The complete developmental pathway in P. argentipes was observed for wild-type promastigotes, GP63 1-6 mutants and mutants transfected with gp63 gene 1. Normal stage differentiation from amastigotes to procyclics, to nectomonads, to haptomonads and to infectious metacyclics was observed. Thus, the highly expressed promastigote forms of GP63, encoded by gp63 genes 1-6, do not appear to be required for nutrient utilization in the bloodmeal during the early stages of development in the sandfly or for midgut attachment and further development. gp63 1-6 genes do, however, play a major protective role against complement-mediated lysis when promastigotes are introduced into the mammalian host.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489664     DOI: 10.1046/j.1365-2958.1998.00689.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

1.  Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro.

Authors:  D Q Chen; B K Kolli; N Yadava; H G Lu; A Gilman-Sachs; D A Peterson; K P Chang
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

2.  Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes.

Authors:  Amanda E Ramer-Tait; Soi Meng Lei; Bryan H Bellaire; Jeffrey K Beetham
Journal:  J Parasitol       Date:  2012-06-04       Impact factor: 1.276

3.  Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology.

Authors:  Ryan K Swenerton; Giselle M Knudsen; Mohammed Sajid; Ben L Kelly; James H McKerrow
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins.

Authors:  J D Hilley; J L Zawadzki; M J McConville; G H Coombs; J C Mottram
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

5.  Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro.

Authors:  Conor R Caffrey; Dietmar Steverding; Ryan K Swenerton; Ben Kelly; Deirdre Walshe; Anjan Debnath; Yuan-Min Zhou; Patricia S Doyle; Aaron T Fafarman; Julie A Zorn; Kirkwood M Land; Jessica Beauchene; Kimberly Schreiber; Heidrun Moll; Alicia Ponte-Sucre; Tanja Schirmeister; Ahilan Saravanamuthu; Alan H Fairlamb; Fred E Cohen; James H McKerrow; Jennifer L Weisman; Barnaby C H May
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

6.  The genetic toolbox for Leishmania parasites.

Authors:  Sigrid C Roberts
Journal:  Bioeng Bugs       Date:  2011-11-01

Review 7.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Design of protease-resistant pexiganan enhances antileishmanial activity.

Authors:  Manjusha M Kulkarni; Anna Karafova; Wojciech Kamysz; Bradford S McGwire
Journal:  Parasitol Res       Date:  2014-05       Impact factor: 2.289

9.  Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.

Authors:  Deborah E Dobson; Shaden Kamhawi; Phillip Lawyer; Salvatore J Turco; Stephen M Beverley; David L Sacks
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

10.  Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein.

Authors:  Sally Corradin; Adriana Ransijn; Giampietro Corradin; Jacques Bouvier; Maria Belen Delgado; Jimena Fernandez-Carneado; Jeremy C Mottram; Guy Vergères; Jacques Mauël
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.